Ameriprise’s Nu Skin NUS Stock Holding History

Ameriprise’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,653	Closed	-$164K	–	4083
2025 Q1	$164K	Sell	22,653 -215,584	-90%	-$1.57M	﹤0.01%	3818
2024 Q4	$1.64M	Buy	238,237 +127,474	+115%	+$877K	﹤0.01%	3028
2024 Q3	$816K	Sell	110,763 -134,017	-55%	-$1.25M	﹤0.01%	3302
2024 Q2	$2.58M	Buy	244,780 +21,717	+10%	+$275K	﹤0.01%	2750
2024 Q1	$3.08M	Buy	223,063 +24,856	+13%	+$388K	﹤0.01%	2652
2023 Q4	$3.85M	Sell	198,207 -907	-0.5%	-$16.7K	﹤0.01%	2533
2023 Q3	$4.22M	Sell	199,114 -2,637	-1%	-$68.5K	﹤0.01%	2417
2023 Q2	$6.7M	Sell	201,751 -16,172	-7%	-$595K	﹤0.01%	2124
2023 Q1	$8.57M	Sell	217,923 -2,985	-1%	-$124K	﹤0.01%	1895
2022 Q4	$9.31M	Buy	220,908 +129,964	+143%	+$5M	﹤0.01%	1798
2022 Q3	$3.03M	Sell	90,944 -2,521	-3%	-$105K	﹤0.01%	2566
2022 Q2	$4.05M	Buy	93,465 +1,319	+1%	+$60.5K	﹤0.01%	2430
2022 Q1	$4.41M	Sell	92,146 -480	-0.5%	-$23.8K	﹤0.01%	2500
2021 Q4	$4.7M	Sell	92,626 -1,929	-2%	-$85.8K	﹤0.01%	2501
2021 Q3	$3.83M	Sell	94,555 -13,708	-13%	-$694K	﹤0.01%	2563
2021 Q2	$6.13M	Sell	108,263 -22,719	-17%	-$1.29M	﹤0.01%	2303
2021 Q1	$6.92M	Buy	130,982 +13,554	+12%	+$738K	﹤0.01%	2172
2020 Q4	$6.42M	Sell	117,428 -17,016	-13%	-$895K	﹤0.01%	2094
2020 Q3	$6.74M	Buy	134,444 +1,593	+1%	+$75.5K	﹤0.01%	1866
2020 Q2	$5.08M	Sell	132,851 -29,675	-18%	-$954K	﹤0.01%	2055
2020 Q1	$3.55M	Sell	162,526 -2,162	-1%	-$65.1K	﹤0.01%	2138
2019 Q4	$6.75M	Sell	164,688 -6,999	-4%	-$286K	﹤0.01%	2041
2019 Q3	$7.3M	Sell	171,687 -145,160	-46%	-$6.09M	﹤0.01%	1938
2019 Q2	$15.6M	Buy	316,847 +23,558	+8%	+$1.2M	0.01%	1352
2019 Q1	$14M	Buy	293,289 +37,295	+15%	+$2.26M	0.01%	1412
2018 Q4	$15.7M	Sell	255,994 -15,899	-6%	-$1.07M	0.01%	1221
2018 Q3	$22.4M	Buy	271,893 +87,922	+48%	+$6.99M	0.01%	1210
2018 Q2	$14.4M	Buy	183,971 +40,250	+28%	+$3.12M	0.01%	1435
2018 Q1	$10.6M	Sell	143,721 -26,740	-16%	-$1.9M	﹤0.01%	1619
2017 Q4	$11.6M	Sell	170,461 -29,140	-15%	-$1.88M	0.01%	1499
2017 Q3	$12.3M	Sell	199,601 -14,333	-7%	-$880K	0.01%	1417
2017 Q2	$13.4M	Sell	213,934 -212,361	-50%	-$12.1M	0.01%	1311
2017 Q1	$23.7M	Buy	426,295 +101,519	+31%	+$5.23M	0.01%	899
2016 Q4	$15.5M	Sell	324,776 -86,964	-21%	-$4.87M	0.01%	1163
2016 Q3	$26.7M	Sell	411,740 -62,183	-13%	-$3.5M	0.01%	768
2016 Q2	$21.9M	Sell	473,923 -26,749	-5%	-$1.08M	0.01%	853
2016 Q1	$19.2M	Buy	500,672 +183,576	+58%	+$6.07M	0.01%	921
2015 Q4	$12M	Sell	317,096 -222,996	-41%	-$8.22M	0.01%	1303
2015 Q3	$22.3M	Buy	540,092 +173,494	+47%	+$7.45M	0.01%	870
2015 Q2	$17.3M	Sell	366,598 -478,729	-57%	-$25.9M	0.01%	1125
2015 Q1	$50.9M	Buy	845,327 +361,572	+75%	+$18.4M	0.03%	523
2014 Q4	$21.1M	Buy	483,755 +481,782	+24,419%	+$21.3M	0.01%	930
2014 Q3	$89K	Sell	1,973 -444,131	-100%	-$23.6M	﹤0.01%	3726
2014 Q2	$33M	Buy	446,104 +53,740	+14%	+$4.24M	0.02%	729
2014 Q1	$32.5M	Buy	392,364 +100,758	+35%	+$8.85M	0.02%	727
2013 Q4	$40.3M	Sell	291,606 -58,881	-17%	-$6.93M	0.02%	624
2013 Q3	$33.6M	Sell	350,487 -12,128	-3%	-$1.03M	0.02%	720
2013 Q2	$22.2M	Buy	+362,615	New	+$20.1M	0.02%	914

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise's NUS Position: Q2 2025 in Review

Ameriprise sold out of Nu Skin (NUS) in Q2 2025, closing a stake of 22,653 shares — an estimated $164K sold.

Ameriprise first reported a position in NUS in Q2 2013 and held it in 48 quarters. The position peaked at $50.9M in Q1 2015. 179 funds tracked by Wall St. Rank hold NUS as of Q2 2025.

Ameriprise reported no remaining Nu Skin position as of Q2 2025 after selling out during the quarter.
Ameriprise sold 22,653 Nu Skin shares in Q2 2025, an estimated $164K.
Ameriprise first reported a position in Nu Skin in Q2 2013 and held it in 48 quarters.
Ameriprise's Nu Skin position peaked at $50.9M in Q1 2015.
179 funds tracked by Wall St. Rank held Nu Skin as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.